These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25708331)

  • 1. Effects of preventive administration of oxidized dextran on liver injury and reparative regeneration in mice infected with influenza A/H5N1 virus.
    Shkurupy VA; Potapova OV; Sharkova TV; Shestopalov AM; Troitskii AV
    Bull Exp Biol Med; 2015 Feb; 158(4):483-8. PubMed ID: 25708331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental study of the efficiency of oxidized dextran for prevention of influenza A/H5N1.
    Shkurupy VA; Potapova OV; Sharkova TV; Troitskii AV; Gulyaeva EP; Bystrova TN; Shestopalov AM
    Bull Exp Biol Med; 2014 Nov; 158(1):112-4. PubMed ID: 25403410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive efficacy of oxidized dextran and pathomorphological processes in mouse lungs in avian influenza A/H5N1.
    Potapova OV; Shkurupiy VA; Sharkova TV; Troitskiy AV; Lusgina NG; Shestopalov AM
    Bull Exp Biol Med; 2011 Apr; 150(6):707-10. PubMed ID: 22235423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive Effects of Oxidized Dextran on Functional Activity of Pulmonary Macrophages in Mice Infected with Influenza A Virus.
    Potapova OV; Cherdantseva LA; Kovner AV; Sharkova TV; Troitskii AV; Shestopalov AM; Shkurupy VA
    Bull Exp Biol Med; 2018 May; 165(1):57-60. PubMed ID: 29796811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural changes in the liver of mice infected with avian influenza virus subtype H5N1.
    Sharkova TV; Potapova OV; Shkurupy VA; Shestopalov AM; Drozdov IG; Shestopalova LV
    Bull Exp Biol Med; 2008 Aug; 146(2):243-5. PubMed ID: 19145328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomorphologic manifestations in mice liver infected with influenza A/H5N1, A/goose/Krasnoozerskoye/627/05 strain.
    Potapova OV; Sharkova TV; Shkurupiy VA; Shestopalov AM
    Clin Dev Immunol; 2013; 2013():342686. PubMed ID: 24454472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional changes in pulmonary macrophages and lungs of mice infected with influenza virus A/H5N1 A/goose/Krasnoozerskoye/627/05.
    Kovner AV; Anikina AG; Potapova OV; Sharkova TV; Cherdanceva LA; Shkurupy VA; Shestopalov AM
    Bull Exp Biol Med; 2012 Jun; 153(2):229-32. PubMed ID: 22816090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphofunctional changes in the lung vascular endotheliocytes in mice with influenza A/H5N1 A/Goose/Krasnoozerskoye/627/05.
    Kovner AV; Potapova OV; Shkurupy VA
    Bull Exp Biol Med; 2013 Feb; 154(4):476-9. PubMed ID: 23486585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of profibrotic growth factors and their receptors by mouse lung macrophages and fibroblasts under conditions of acute viral inflammation in influenza A/H5N1 virus.
    Anikina AG; Shkurupii VA; Potapova OV; Kovner AV; Shestopalov AM
    Bull Exp Biol Med; 2014 Apr; 156(6):833-7. PubMed ID: 24824710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection.
    Salomon R; Hoffmann E; Webster RG
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12479-81. PubMed ID: 17640882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
    Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.
    Kashima Y; Ikeda M; Itoh Y; Sakoda Y; Nagata T; Miyake T; Soda K; Ozaki H; Nakayama M; Shibuya H; Okamatsu M; Ishigaki H; Ishida H; Sawai T; Kawaoka Y; Kida H; Ogasawara K
    Vaccine; 2009 Dec; 27(52):7402-8. PubMed ID: 19747993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
    Asahi-Ozaki Y; Itamura S; Ichinohe T; Strong P; Tamura S; Takahashi H; Sawa H; Moriyama M; Tashiro M; Sata T; Kurata T; Hasegawa H
    Microbes Infect; 2006 Oct; 8(12-13):2706-14. PubMed ID: 16968669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes in the brain of mice infected with influenza A/H5N1 virus.
    Potapova OV; Shkurupy VA; Sharkova TV; Shestopalov AM
    Bull Exp Biol Med; 2009 Dec; 148(6):892-5. PubMed ID: 21116500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
    Major D; Chichester JA; Pathirana RD; Guilfoyle K; Shoji Y; Guzman CA; Yusibov V; Cox RJ
    Hum Vaccin Immunother; 2015; 11(5):1235-43. PubMed ID: 25714901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.